Dividend Stock Portfolio For Retirement: 10 Stocks to Buy

Page 9 of 9

1. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 83

Pfizer Inc. (NYSE:PFE) is an American multinational pharmaceutical and biotech company. The last three years have been challenging for its investors. The company’s COVID-19 vaccine and treatment initially sent the stock soaring during the pandemic, but once demand peaked, the share price followed suit. The stock has declined by nearly 50% over the past three years.

Looking ahead, Pfizer Inc. (NYSE:PFE)’s pipeline offers potential for future growth even though it has not yet translated into new revenue. Among its most notable candidates are Elrexfio (elranatamab-bcmm) and Sigvotatug vedotin. Elrexfio is already approved for certain multiple myeloma patients, and ongoing phase 3 trials could significantly expand its use. Sigvotatug vedotin, an antibody-drug conjugate acquired through Pfizer’s 2023 purchase of Seagen, has shown strong results in phase 3 trials as a treatment for advanced lung cancer.

In total, Pfizer Inc. (NYSE:PFE)currently has 18 oncology drugs in phase 3 development, with eight of them projected to potentially generate over $1 billion in annual sales each by 2030. Moreover, the company’s dividend is keeping it afloat in times like these. It has been growing its dividends for 15 consecutive years and currently pays a quarterly dividend of $0.43 per share. As of September 21, the stock has a dividend yield of 7.16%.

While we acknowledge the potential of PFE to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PFE and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best S&P 500 Dividend Stocks to Invest in and 10 Safest High Dividend Stocks to Buy Now.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 9 of 9